Merkliste 
 1 Ergebnisse 
 
1

A phase 2 multiple ascending dose study of the inhaled pan-..:

Singh, Dave ; Bogus, Maxim ; Moskalenko, Valentyn...
Singh , D , Bogus , M , Moskalenko , V , Lord , R , Moran , E J , Crater , G D , Bourdet , D L , Pfeifer , N D , Woo , J , Kaufman , E , Lombardi , D A , Weng , E Y , Nguyen , T , Woodcock , A , Haumann , B & Saggar , R 2021 , ' A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19 ' , European Respiratory Journal , vol. 58 , no. 4 , 2100673 . https://doi.org/10.1183/13993003.00673-2021.  , 2021